An alternative method to dithiothreitol treatment for antibody screening in patients receiving daratumumab

Transfusion

Volumn 55, Issue 9, 2015, Pages 2292-2293

  Schmidt, Amy E ^a   Kirkley, Scott ^a   Patel, Nisha ^a   Masel, Debra ^a   Bowen, Renee ^a   Blumberg, Neil ^a   Refaai, Majed A ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DARATUMUMAB; DITHIOTHREITOL; INSULIN; SOMATOSTATIN;

ALTERNATIVE MEDICINE; ANTIBODY SCREENING; B LYMPHOCYTE; BLOOD BANK; BLOOD GROUP KELL SYSTEM; BONE MARROW TRANSPLANTATION; CALCIUM SIGNALING; CANCER PATIENT; CELL ADHESION; CLINICAL TRIAL (TOPIC); COOMBS TEST; CROSS LINKING; EFFECTOR CELL; ERYTHROCYTE; HUMAN; LETTER; MULTIPLE MYELOMA; SIGNAL TRANSDUCTION; ANIMAL; MALE; SECRETION (PROCESS);

ANIMALS; INSULIN; MALE; SOMATOSTATIN;

EID: 84941776674     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13174     Document Type: Letter

References (5)

1. Chapuy CI, Nicholson RT, Aguad MD, et al,., Resolving the daratumumab interference with blood compatibility testing. Transfusion 2015; 55: 1545-54.
2. Khagi Y, Mark TM,. Potential role of daratumumab in the treatment of multiple myeloma. Onco Targets Ther 2014; 7: 1095-100.
3. Deaglio S, Mehta K, Malavasi F,. Human CD38: a (r)evolutionary story of enzymes and receptors. Leuk Res 2001; 25: 1-12.
4. Malavasi F, Deaglio S, Funaro A, et al., Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology. Physiol Rev 2008; 88: 841-86.
5. Plesner T, Lokhorst HM, Gimsing P, et al., Daratumumab, a CD38 monoclonal antibody in patients with multiple myeloma-data from a dose-escalation phase I/II study. 54th ASH annual meeting and exposition abstracts book; 2012 Dec 8-11; Atlanta, GA.